Manufacture of factor H (FH) and FH-derivatives from plasma

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9109044
APP PUB NO 20130102537A1
SERIAL NO

13633057

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides compositions and pharmaceutical formulations of Factor H derived from plasma. Also provided are methods for the manufacture of the Factor H compositions and formulations, as well as methods for the treatment of diseases associated with Factor H dysfunction.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TAKEDA PHARMACEUTICAL COMPANY LIMITEDOSAKA-SHI OSAKA 541-0045

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bairstow, Shawn F Gurnee, US 15 112
Johnson, Richard Mundelein, US 180 2416
Madlener, Ruth Vienna, AT 13 67
Ramachandran, Sindhu Lake Zurich, US 13 75
Schwarz, Hans-Peter Vienna, AT 143 1170
Teschner, Wolfgang Vienna, AT 52 519

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 18, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00